首页> 外文期刊>Contraception >Cervical preparation for second-trimester surgical abortion prior to 20 weeks' gestation: SFP Guideline #2013-4
【24h】

Cervical preparation for second-trimester surgical abortion prior to 20 weeks' gestation: SFP Guideline #2013-4

机译:在20周之前的妊娠期妊娠期妊娠宫颈准备:SFP指南#2013-4

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

For a dilation and evacuation (D&E) procedure, the cervix must be dilated sufficiently to allow passage of operative instruments and products of conception without injuring the uterus or cervical canal. Preoperative preparation of the cervix reduces the risk of cervical laceration and uterine perforation. The cervix may be prepared with osmotic dilators, pharmacologic agents or both. Dilapan-S? and laminaria are the two osmotic dilators currently available in the United States. Laminaria tents, made from dehydrated seaweed, require 12-24 h to achieve maximum dilation. Dilapan-S?, made of synthetic hydrogel, achieves significant dilation within 4 h and is thus preferable for same-day procedures. A single set of one to several dilators is usually adequate for D&E before 20 weeks' gestation. Misoprostol, a prostaglandin E1 analogue, is sometimes used instead of osmotic dilators. It is generally regarded as safe and effective; however, misoprostol achieves less dilation than overnight osmotic tents. The literature supports same-day cervical preparation with misoprostol or Dilapan-S? up to 18 weeks' gestation. As the evidence regarding alternative regimens increases, highly experienced D&E providers may consider same-day regimens at later gestations utilizing serial doses of misoprostol or a combination of osmotic and pharmacologic agents. Misoprostol use as an adjunct to overnight osmotic dilation is not significantly beneficial before 19 weeks' gestation. Limited data demonstrate the safety of misoprostol before D&E in patients with a prior cesarean delivery. Mifepristone, a progesterone receptor antagonist, is also effective for cervical preparation prior to D&E, although data to support its use are limited. The Society of Family Planning recommends preoperative cervical preparation to decrease the risk of complications when performing a D&E. Since no single protocol has been found to be superior in all situations, clinical judgment is warranted when selecting a method of cervical preparation.
机译:对于扩张和疏散(D& e)程序,必须充分扩张子宫颈,以便在不损害子宫或颈部管的情况下通过操作仪器和产品的通过。术前宫颈的制剂降低了宫颈损伤和子宫穿孔的风险。宫颈可以用渗透稀释剂,药理剂或两者制备。德帕潘 - Laminaria是目前在美国目前可用的两种渗透扩张器。由脱水海藻制成的Laminaria帐篷需要12-24小时来实现最大扩张。由合成水凝胶制成的Dilapan-S?,在4小时内实现显着的扩张,因此优选的是同日制程序。一组一组到几个扩张器通常适用于20周之前的D& e在妊娠之前。有时使用误解剂,前列腺素E1类似物代替渗透扩张器。它通常被认为是安全有效的;然而,Misoprostol比过夜渗透性帐篷达到更少的扩张。该文献支持与米索前列醇或德拉帕山的当天宫颈制剂?最多18周的妊娠。由于有关替代方案的证据增加,高度经验丰富的D& e提供商可以在以后的妊娠上使用连续剂量的米索前列醇或渗透和药物剂的组合来考虑同日方案。 Misoprostol用作辅助渗透渗透扩张的辅助,在19周之前没有显着有益。有限的数据证明了D& E在患有先前剖宫产的患者之前的乳腺醇的安全性。山羊酮是一种黄体酮受体拮抗剂,对D&amp之前的宫颈制剂也有效; e,尽管支持其使用的数据是有限的。家庭计划协会推荐术前宫颈制剂,以减少在执行D& e时减少并发症的风险。由于在所有情况下没有发现单一方案优越,因此在选择宫颈制剂方法时保证临床判断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号